ViroPharma (VPHM) Fair Value $46-$52 in M&A Scenarios - Deutsche Bank
Tweet Send to a Friend
On Friday Bloomberg sources said ViroPharma Inc. (Nasdaq: VPHM) has attracted takeover interest from Sanofi (NYSE: SNY) and Shire (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


